Search Results
Nov 19, 2025, 09:59 ET Michael Baker International Names Scott Rodseth, P.E., P.Eng., Office Executive - Chicago
Baker in 2022 as Department Manager – Construction Services (CS) before being promoted to Director of Transportation, where he oversaw the Structures, Highways and CS departments serving the Illinois and Iowa markets. His oversight of the CS team also extended to Michigan, Indiana, Wisconsin and Minnesota.
More news about: Michael Baker International
Nov 18, 2025, 03:50 ET 2025 Esports Innovation and Communication Seminar Held in Mudanjiang, China
hosted a growing slate of international tournaments, with three major esports competitions for League of Legends, Honor of Kings, and CS2 scheduled to take place in the country in November. The League of Legends 2025 World Championship traveled through Beijing and
More news about: CCTV Animation Group
Nov 18, 2025, 02:53 ET By Popular Demand CS Analytical Hosting Q&A Webinar on USP 661.1 and USP 661.2
About CS Analytical LaboratoryThe only FDA regulated, cGMP laboratory dedicated exclusively to the complex world of drug and medical device container and package qualification testing, the CS Analytical Team includes the world's leading experts
More news about: CS Analytical
Nov 17, 2025, 21:26 ET PEGATRON Strengthens AI Infrastructure Collaboration with Together AI and 5C for NVIDIA GB300 NVL72 and NVIDIA HGX B200 Liquid-Cooled Rack Deployment in U.S. Data Centers
AI infrastructure solutions. Collectively, these initiatives deliver an L12 total solution capacity, underscoring Pegatron and 5C's end-to-end expertise in rack-level AI system and networking engineering, cooling solutions integration, and full data center deployment. With Together
More news about: Pegatron Corporation
Nov 17, 2025, 20:46 ET Czinger Dallas Announces Delivery of "Point of No Return" 21C V Max Hypercar to the Barchetta Collection
Rock and Roll theme. It is a masterpiece." The delivery underscores the growing demand and excitement generated by the Czinger 21C's proven capabilities, including its multiple consecutive track records achieved during the recent California Gold Rush campaign.
More news about: US Auto Trust
Nov 14, 2025, 20:47 ET PMET Resources Files NI 43-101 Technical Report on the CV5 Lithium-Only Feasibility Study on its Shaakichiuwaanaan Project
world's largest pollucite-hosted caesium pegmatite Mineral Resource at the Rigel and Vega zones with 0.69 Mt at 4.40% Cs2O (Indicated), and 1.70 Mt at 2.40% Cs2O (Inferred). For further information, please contact us at
More news about: PMET Resources Inc.
Nov 13, 2025, 17:07 ET 2025's Leading Managed Detection & Response Providers Ranked by Info-Tech Research Group for Cybersecurity and Resilience
to recommend, feature scores, net emotional footprint score, and vendor capabilities. These dimensions are aggregated into a Composite Score (CS), which reflects overall user satisfaction and determines the product's placement within the Data Quadrant. The firm's methodology ensures that rankings
More news about: Info-Tech Research Group
Nov 13, 2025, 08:28 ET Netwrix to Showcase Identity-Driven Data Security for Microsoft 365 Copilot at Microsoft Ignite 2025
Outlook, providing visibility into data usage and provenance. Active Directory Certificate Services (AD CS) Protection adds blocking of unauthorized certificate enrollments, an industry first among Identity Threat Detection and Response vendors.
More news about: Netwrix
Nov 12, 2025, 08:00 ET Hour of AI Unveils 100+ Free Activities to Help Demystify AI for Educators, Families, and Kids
student in every school has the opportunity to learn about artificial intelligence (AI) and computer science (CS) as part of their core K-12 education. The leading provider of K-12 AI and CS education curriculum across the globe, Code.org also organizes the annual Hour of AI campaign, building on the
More news about: Code.org
Nov 12, 2025, 06:30 ET PMET Resources to Expand Land Position in James Bay Region
world's largest pollucite-hosted caesium pegmatite Mineral Resource at the Rigel and Vega zones with 0.69 Mt at 4.40% Cs2O (Indicated), and 1.70 Mt at 2.40% Cs2O (Inferred).
More news about: PMET Resources Inc.
Nov 10, 2025, 02:20 ET Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA
About CS1 CS1 is an orally administered histone deacetylase inhibitor (HDACi) in development as a well-tolerated, disease-modifying therapy for pulmonary arterial hypertension (PAH) with favorable safety profile. Acting through epigenetic modulation, CS1 targets
More news about: Cereno Scientific
Nov 10, 2025, 02:16 ET Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA
About CS1 CS1 is an orally administered histone deacetylase inhibitor (HDACi) in development as a well-tolerated, disease-modifying therapy for pulmonary arterial hypertension (PAH) with favorable safety profile. Acting through epigenetic modulation, CS1 targets
More news about: Cereno Scientific
Nov 09, 2025, 03:00 ET Première thérapie mondiale d'édition génique ciblant l'APOC3 pour le traitement de l'hyperlipidémie
clinique, avait précédemment mis au point le CS-101, une thérapie d'édition génique ex vivo qui a traité avec succès des dizaines de patients atteints de β-thalassémie et de drépanocytose. L'entreprise fait progresser le CS-121, la première thérapie d'édition génétique in
More news about: CorrectSequence Therapeutics
Nov 07, 2025, 08:52 ET Weltweit erste, auf APOC3 abzielende Gen-Editing-Therapie zur Behandlung von Hyperlipidämie
des CS-121 IIT sind Professor Huan Zhou und Doktor Zhili Wu the First Affiliated Hospital der Anhui Medical University. Correctseq, ein innovatives Biotechnologieunternehmen in der klinischen IND-Phase, hat zuvor CS-101 entwickelt,
More news about: CorrectSequence Therapeutics
Nov 07, 2025, 08:24 ET La primera terapia de edición genética del mundo dirigida a APOC3 para la hiperlipidemia
principales del CS-121 IIT son el profesor Huan Zhou y el doctor Zhili Wu the First Affiliated Hospital of Anhui Medical University. Correctseq, una innovadora empresa de biotecnología en la etapa clínica IND, desarrolló previamente CS-101, una terapia de edición
More news about: CorrectSequence Therapeutics
Nov 06, 2025, 21:22 ET 世界初の APOC3 を標的とした高脂血症向け遺伝子編集治療薬
を標的とするベース編集療法 CS-121 に関する Investigator-Initiated Trial（IIT）の最初の患者への投与が無事完了し、患者が退院したことを発表した。本試験はカイロミクロン血症/高トリグリセリド血症を対象として行われている。 この患者は乳糜ミクロンド症と診断されており、長年にわたり空腹時トリグリセリド（TG）値が12.5 mmol/Lを超える状態が続き、急性膵炎を繰り返していた。CS-121 の用量漸増型 I IT において、低用量の単回投与後3日以内に、患者の空腹時TG値は大幅に低下し、有害事象は認められなかった。
More news about: CorrectSequence Therapeutics
Nov 06, 2025, 19:10 ET ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut
presentation of CS2015 at an international academic conference. The full content of the abstract and eposter is now officially available on the ACAAI website. Key highlights of the presentation: CS2015 features an asymmetric
More news about: CStone Pharmaceuticals
Nov 06, 2025, 19:00 ET 里程碑突破！全球首個APOC3基因編輯臨床治療高血脂獲得成功
正序生物 CS-121 首例高乳糜微粒血症患者完成給藥，顯示良好安全性及 顯著療效 上海
More news about: CorrectSequence Therapeutics
Nov 06, 2025, 05:49 ET Společnost Huawei představila novinky v digitální transformaci pro malé a střední firmy
content:https://www.prnewswire.com/cs/tiskova-zprava/spolenost-huawei-pedstavila-novinky-v-digitalni-transformaci-pro-male-a-stedni-firmy-302607023.html
More news about: Huawei Europe
Nov 05, 2025, 19:42 ET The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
investigators of the CS-121 IIT are Professor Huan Zhou and Doctor Zhili Wu from the First Affiliated Hospital of Anhui Medical University. Correctseq, an innovative biotechnology company at the IND clinical stage, previously developed CS-101, an ex vivo
More news about: CorrectSequence Therapeutics
Nov 05, 2025, 19:00 ET The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
investigators of the CS-121 IIT are Professor Huan Zhou and Doctor Zhili Wu from the First Affiliated Hospital of Anhui Medical University. Correctseq, an innovative biotechnology company at the IND clinical stage, previously developed CS-101, an ex vivo
More news about: CorrectSequence Therapeutics
Nov 05, 2025, 14:35 ET CTEK Unveils Next-Generation Lineup At SEMA 2025 - Smarter, Stronger, And More Connected Than Ever
CS ONE (Gen 2) – The Future of Smart Charging Unveiled for the first time at SEMA 2025, the CS ONE (Gen 2) introduces built-in Wi-Fi and Bluetooth connectivity and a redesigned CTEK App, giving users complete remote control over charging and monitoringCS ONE
More news about: CTEK
Nov 04, 2025, 17:45 ET ITAÚ UNIBANCO - FATO RELEVANTE - PROJEÇÕES 2025
Alíquota efetiva de IR/CS
More news about: Itaú Unibanco Holding S.A.
Nov 04, 2025, 07:00 ET Axcelis Announces Financial Results for Third Quarter 2025
Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased to report record CS&I revenue in the quarter, reflecting the success of our aftermarket strategy and the continued expansion of our installed base. We are executing on
More news about: Axcelis Technologies, Inc.
Nov 04, 2025, 04:15 ET The Fabric of Change: Weaving a Legacy of Empowerment and Compassion with Style Baazar's CSR Initiatives
www.stylebaazar.in Media Contact Details: Mr. Abinash SinghCCO, CS & Head-Legal & [email protected]
More news about: Baazar Style Retail Limited (BSRL)